舒血宁注射液治疗缺血性中风(脑梗塞)60例临床疗效观察  

Investigation on Clinical Effect of Shuxuening Injection for Ischemic Apoplexy (Cerebral Infarction) on 60 Cases

作　　者：花根才[1] 冯青根[1] 范华昌[1] 

机构地区：[1]上海市普陀区中心医院,上海200062

出　　处：《中成药》2002年第1期34-36,共3页Chinese Traditional Patent Medicine

摘　　要：目的 :观察国产银杏叶提取物制剂舒血宁注射液对缺血性中风 (脑梗塞 )的治疗作用。方法 :92例患者随机分为治疗组即A组 6 0例 ,对照组即B组 32例。A组应用A液即舒血宁注射液 2 5mL加入 0 .9%生理盐水 5 0 0mL内静脉滴注 ,B组应用B液即金钠多注射液 2 5mL加入 0 .9%生理盐水 5 0 0mL内静脉滴注 ,均每日 1次 ,15d为 1疗程 ,进行双盲对照。结果 :舒血宁注射液对缺血性脑梗塞临床有效率达 90 % ,与进口同类产品“金钠多”注射液对照无明显差异 ,P >0 .0 5。对四肢关节及综合功能等治疗前后计分测定比较 ,2组均有显著意义。中医辨证分型疗效发现舒血宁对风痰瘀血、痹阻经脉疗效显著。对气虚血瘀也有满意疗效。结论 :国产舒血宁注射液对缺血性中风 (脑梗塞 )具有较好的治疗作用。Objective: To investigate the clinical effect of Shuxuening Injection (Folium Ginkgo extract preparation, SXN) for ischemic apoplexy (cerebral infarction). Methods: 92 patients with ischemic apoplexy were randomly divided into the therapeutic group (Group A, 60 cases) and the control group (Group B, 32 cases). Group A was treated by IV drip of SXN 25mL in 500mL of 0.9% physiological soline. Group B was treated by IV drip of Jinnaduo Injection 25mL in 500mL of 0.9% Physiological saline. Both groups were given drugs once a day, 15 days constituting a single therapeutic course. The study was carried out by using the double blind contrast method. Results: The effective rate of SXN was 90%. There was no obvious difference in effective rate between Group A and Group B ( P >0.05). The limbs articulation and combination functions before and after treatment were evaluated and compared. Both groups had obvious significance. SXN showed a remarkable effect for wind phlegm static blood and impediment of vital energy stagnating at main channel, also for qi vacuity blood stasis. Conclusion: SXN has been used for the treatment of ischemic apoplexy with favorable results.

关 键 词：舒血宁注射液 缺血性中风 辨证分型 急性血管病 

分 类 号：R277.733.3[医药卫生—中医学]